key: cord-0258516-fg5odq9f
authors: Shen, L.; Triche, T. J.; Dien Bard, J.; Biegel, J. A.; Judkins, A. R.; Gai, X.
title: Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion
date: 2021-09-15
journal: nan
DOI: 10.1101/2021.09.12.21263475
sha: c2bf35f161b583f74ab7a796b6212607c9eb2358
doc_id: 258516
cord_uid: fg5odq9f

The significantly greater infectivity of the SARS-CoV-2 Delta variants of concern (VOC) is hypothesized to be driven by key mutations that result in increased transmissibility, viral load and/or evasion of host immune response. We surveyed the mutational profiles of Delta VOC genomes between September 2020 and mid-August 2021 and identified a previously unreported mutation pattern at amino acid position 142 in the N-terminal domain (NTD) of the spike protein which demonstrated multiple rounds of mutation from G142 to D142 and back. This pattern of frequent back mutations was observed at multiple time points and across Delta VOC sub-lineages. The etiology for these recurrent mutations is unclear but raises the possibility of host-directed editing of the SARS-CoV-2 genome. Within Delta VOC this mutation is associated with higher viral load, further enhanced in the presence of another NTD mutation (T95I) which was also frequently observed in these cases. Protein modeling of both mutations predicts alterations of the surface topography of the NTD by G142D, specifically disturbance of the 'super site' epitope that binds NTD-directed neutralizing antibodies (NAbs). The appearance of frequent and repeated G142D followed by D142G back mutations is previously unreported in SARS-CoV-2 and may represent viral adaptation to evolving host immunity characterized by increasing frequency of spike NAbs, from both prior infection and vaccine-based immunity. The emergence of alterations of the NTD in and around the main NAb epitope is a concerning development in the ongoing evolution of SARS-CoV-2 which may contribute to increased infectivity, immune evasion and 'breakthrough infections' characteristic of Delta VOC. Future vaccine and therapy development may benefit by recognizing the emergence of these novel spike NTD mutations and considering their impact on antibody recognition, viral neutralization, infectivity, replication, and viral load.

The Delta variant of concern (VOC) quickly overtook other VOCs (Alpha, Beta, Gamma, Epsilon, Lota) and by late August 2021 accounted for over 98% of new COVID-19 cases in the United States (https://covid.cdc.gov/covid-data-tracker/#variant-proportions). SARS-CoV-2 viral loads are significantly higher in both vaccinated and unvaccinated individuals infected by Delta VOC (1) . At least in part this appears to be driven by increased infectivity due to the furin cleavage enhancing P681R mutation (2) . Other potential mechanisms have been proposed, including reduced immune recognition resulting from diminished neutralizing antibody binding to spike protein epitopes, particularly in the receptor binding domain (RBD) of the spike protein (3) .

The evolution of the SARS-CoV includes key mutations in SARS-CoV-2 proteins that interact with host immune system (4) . Viral evolution and genomic diversity have also been shaped by vaccination efforts worldwide (5) . Host immune response to SARS-CoV-2 infection is primarily characterized by antibodies directed against the spike protein, specifically the N-terminal domain (NTD) and the receptor-binding domain (RBD), with the latter being the focus of mRNA vaccines (6, 7) . Novel mutations and new patterns of mutational evolution in the NTD and RBD domains of the spike protein may represent an evolutionary response in the context of both previous infection and worldwide vaccination efforts.

Based on analysis of available Delta VOC genomes reported from September 2020 to mid-August 2021 we identified a spike NTD mutation (G142D) in multiple major sub-lineages of Delta VOC across different ancestral mutation profiles that demonstrated an unusual pattern of frequent back mutations that frequently occurred in concert with a novel NTD mutation (T95I). The G142D mutation was associated with higher viral loads, and this effect was significantly increased by the co-occurrence of T95I.

Ethics approval. Study design conducted at Children's Hospital Los Angeles was approved by the Institutional Review Board under IRB CHLA-16-00429.

SARS-CoV-2 whole genome sequencing. Whole genome sequencing of COVID-19 samples previously confirmed at Children's Hospital Los Angeles to be positive for SARS-CoV-2 by reverse transcription-polymerase chain reaction (RT-PCR) was performed as previously described (8) .

Phylogenetic and structural analysis. Phylogenetic analysis was conducted using the NextStrain phylogenetic pipeline (version 3.0.1) (https://nextstrain.org/). Genbank NC_045512 sequence was included as SARS-CoV-2 reference genome to root the tree. Structure prediction of the hypothetical Delta spike protein with signature mutations was done by: 1) Adding the Delta spike signatures (T19R/T95I/G142D/E156G/F157del/R158del/L452R/T478K/D614G/P681R/D950N); into the fasta sequence from NC_045512.2 (reference genome) and 7C2L, S protein of SARS-CoV-2 in complex bound with antibody 4A8 (https://www.rcsb.org/structure/7C2L): 2) Predicted protein structure was derived using the Phyre2 web portal (normal mode) (9) and one-to-one threading matching using known structures: 6VSB (10), 7L2E (11), 7DK3 (12) and 7C2L (13); and 3) Alignment and superimposition of predicted structures was performed using ChimeraX Matchmaker (14) : 6VSB, 7L2E, 7C2L and 7DK3.

Full-length SARS-CoV-2 sequences are annotated, curated, and monitored using a suite of bioinformatics tools, CHLA-CARD, as previously described (15) (16) (17) . Statistical analysis and visualization were conducted with R (r-project/org).

We analyzed SARS-CoV-2 genomes from Delta (B. Table 1 ). This generally falls with the range of spike missense mutations of non-Delta VOCs (Alpha 10.56, Beta 9.62, Gamma 12.40 in July 2021), and is greater than that observed in non-VOC lineages (7.61 in July 2021). However, Delta VOCs demonstrated a faster rate of increase in mutations per genome for genes S, ORF7a, and ORF7b, as shown in Supplemental Figure 1 . The estimated evolutionary rate by phylogenetic analysis was 26.616 in Delta VOC, compared with 24.906 in the mixed dataset of North America, which consisted of 39.9% Delta VOC, (https://nextstrain.org/ncov/gisaid/north-america?l=clock, 2021-09-01), and 20.815 on 2021-02-25 when Delta VOC was not sampled yet.

We analyzed the distribution and evolutionary pattern of all protein-changing mutations with greater than 2% prevalence in Delta VOC. Our analysis identified Spike G142D ( Figure 1A ) and T95I ( Figure 1B ) mutations which were both recurrent and present in multiple well-separated branches or sub-lineages within the Delta VOC lineage, with prevalence rates of 55.4% and 40.1%, respectively.

Strikingly, G142D was present across almost all major Delta sub-lineages, separated from each other on the phylogenetic tree by one or more coding and non-coding mutations ( Figure 1A ). It appears that G142D was introduced into a Delta VOC major branch in late September 2020, and then again on other smaller major branches beginning in November 2020 ( Figure 1A) .

Back mutation to D142G was identified in multiple branches at various time points, between early January and early July, 2021 ( Figure 1A) . This phenomenon was not observed for other spike protein mutations including T95I ( Figure 1B ). In one representative example, following the back mutation to D142G, the virus then underwent two additional protein-changing mutations (N1074S and ORD1b:P244S) and three synonymous mutations (C5239T/ORF1ab:Y1658=, A26927G/M:E135=, C13019T/ORF1ab:L4252=), and then mutated back to G142D (Figure 2 ).

Using PCR cycle threshold (Ct) values for 27,971 samples and other metadata obtained from NCBI (Bioproject Accession PRJNA731152, SARS-CoV-2 Genome sequencing and assembly -FULGENT, https://www.ncbi.nlm.nih.gov/bioproject/731152, data accessed September 8, 2021) the G142D mutation was linked to lower PCR cycle threshold (Ct) values in Delta VOC genomes. Among all Delta VOC isolates, the Ct values were significantly lower in G142D isolates than in the wild type (20.1±3.92 vs 23.3±3.80) ( Table 1 ). The effect of G142D on the Ct values was evident across all Delta sub-lineages ( Table 2) . This effect was further enhanced by the T95I mutation which was also associated with lower Ct values across multiple sub-lineages within the Delta VOC (Table 3) . Combined, G142D and T95I were associated with additional reduction in Ct values (18.9±3.31 vs 20.1±3.92) and a cumulative increase in viral load (G142D: p= 6.57e-1191 and T95I: p= 9.13e-109 by t-test). These Ct value change patterns were consistent over time (June through August) and across age and gender groups (data not shown). Using a theoretical two-fold increase per Ct cycle, these likely contribute significantly to increased Delta VOC viral loads, as much as a 9.2-fold increase for G142D alone, and up to a 21.1-fold increase when combined with T95I.

Phyre predicted secondary structure shows that G142D plus T95I are associated with the potential conversion of a β -strand to α -helix structure around aa159-167 and aa183-190. The Delta's major NTD region 3-D structural difference is around aa150-158, close to the G142D and E156G+157_158del. This change in surface topography extends up and into the N3-N5 loop antibody binding 'super site'. The combination G142D and T95I with other Delta VOC alterations, including aa157_158del and substitutions of E156G, is predicted to alter the original 4-8 (7L2E) and 4A48 (7C2L) antibody binding epitope, diminishing antibody binding to this region. Among them, new antibody facing residues are likely exposed by this change in conformation, including TYR145, LYS150, SER151, TRP152 ASP176, GLU178, which are predicted to diminish binding by repelling antibody binding. Thus, the G142D and T95I mutations are predicted to alter the surface topography of the NTD, including the antibody binding "super site" formed by the N3 and N5 loop structures (Figure 3) . Within Delta, the G142D further caused TRP152 position to shift outwards to the antibody 41-8 side by 10.786 Å than Delta without G142D, and by 13.457Å than non-Delta template 7L2E (Figure 3 ). Missense3D predicted a 186 Å^3 enlargement of the pocket at T95I, yet T95I is not changing the topology as significantly as G142D which is not surprising for a buried residue. In the absence of both mutations, the β -strand is conserved (Supplemental Figure 2) . Interestingly, if only T95I is absent, the native β -strand is predicted to be converted to a disorganized coil around aa159-165, but the aa183-190 region remains α -helical. All predictions based on these NTD mutations had the prominent protrusion of a loop structure in the furin cleavage site around aa681-685, associated with the P681R mutation, thus retaining the enhanced protease cleavage of S1 from S2 associated with this mutation (data not shown).

Through comprehensive phylogenetic analysis, mutation profiling, and public database mining, we identified a recurrent and frequently repeated back mutation at spike protein G142 in the NTD region of the spike protein. The repeated gain, loss, and regain of this mutation at the same position across multiple sub-lineages has not to our knowledge been reported in SARS-CoV-2 or other coronaviruses. The basis for this change is unclear but the mutational pattern is inconsistent with the previously observed fidelity rate of SARS-CoV-2 polymerase, which is enhanced by nsp14 ExoN proofreading (20) . However, it seems likely that random RNA polymerase errors changes are not the only driver of changes in the SARS-CoV-2 genome. Mutational surveys of published SARS-CoV-2 genomes reveal overrepresentations of nucleotide changes bearing the signature of RNA editing: adenosine-to-inosine (A-G) changes from ADAR deaminases and cytosine-to-uracil (C-U) changes from APOBEC deaminases (21) (22) (23) (24) . The role of APOBEC and ADAR proteins in host innate immunity and their viral directed activities raises the possibility of host immunity contributing to the intra-host heterogeneity observed in the SARS-CoV-2 genome (22, (24) (25) (26) . Indeed, this has been proposed as the underlying mechanism for the D614G mutation (27) . Whether the observed frequent mutation and back mutation events at position 142 reported here are due to RNA editing is of interest and requires analysis beyond the scope of this study.

Delta VOC cases with spike NTD mutation G142D demonstrated increased viral loads, an effect that was further enhanced in the presence of the second NTD mutation (T95I) this study. Precisely how these changes lead to higher viral loads and perhaps contribute to increased transmission in the Delta VOC remains to be fully elucidated. However, our results suggest that reduced NAb binding to the NTD is one potential mechanism that deserves further investigation. The G142D mutation is located in close proximity to the alterations of E156G and DEL157-158 reported in all Delta VOC that is part of the N3 loop of the NTD 'super site' epitope recognized by NTD-directed NAbs and associated with reduced viral neutralization (28) (29) (30) (31) (32) . Despite the well-known challenges of in-silico protein structure e prediction on the spike protein (e.g., preand post-fusion conformation, the impact of D614G and P681R mutations on furin cleavage structure, and native spike conformation vs various mutated spike protein and their effect on antibody binding to different NTD or RBD epitopes) all of our structural predictions modelled against different templates (native, NTD-or RBD antibody-bound) consistently predicted that G142D and T95I mutations contribute to significant changes in the NTD secondary structure, including the potential conversion of β -strand to α -helix around aa159-167 and 183-190 regions, hydrogen-bond changes due to altered residue charge at G142D, an enlarged pocket at T95I, and overall three dimensional NTD surface topography that is unfavorable to NAb binding in the presence of other Delta VOC signature mutations. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 15, 2021. ;  The increased frequency of Spike mutations, especially in the NTD, in the recently emergent Delta and Mu VOCs has not been observed in previous VOCs. Additional sequence data collection and analysis will be required to determine if this is an example of host-cell induced RNA editing or other mechanism that results in rapid generation of multiple variants, from which those that are biologically more 'fit' can emerge and re-emerge (21) (22) (23) . Whatever the underlying mechanism, this change raises important questions about the evolutionary trajectory of SARS-CoV-2 with potentially significant clinical implications for reinfections and vaccine breakthrough infections which have become hallmarks of the Delta VOC. The combination of diminished immune recognition in both the RBD and NTD, here linked to a recurring mutation at G142D, in concert with a T95I mutation, raises the question of whether the observed mutations of the Delta VOC may at least in part reflect evolutionary adaptation to the growing percentage of the population immune to prior variants, whether by previous infection or vaccinations that primarily target the spike RBD, as this pandemic continues. If so, increased vigilance will be required to detect emergence of new NTD region mutations that may confer even greater immune evasion, replication, and transmission advantages to future Delta sub-lineages and SARS-CoV-2 VOCs yet to emerge.

We would like to acknowledge all members of the Department of Pathology and Laboratory Medicine (PLM) at Children's Hospital Los Angeles for dedication towards providing excellent patient care throughout the pandemic, including especially the rapid launch of both the COVID-19 diagnostic test in the Clinical Microbiology and Virology Laboratory and the SARS-CoV-2 whole genome sequencing assay at the Center for Personalized Medicine in March 2020, both with the support of Thermo Fisher and Paragon Genomics, with whom these assays were developed. We would like to acknowledge the frontline healthcare workers who remain devoted in the fight against COVID-19. We would also like to acknowledge all institutions that have contributed the SARS-CoV-2 sequences timely, as well as NCBI, GISAID, and Nextstrain for providing valuable resources for SARS-CoV-2 genomics.

The authors declare no potential conflict of interest . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; Figure 3 . Superimposed 7L2E and Delta mutant spike protein structure at the NTD region predicts altered surface topography unfavorable to NAb binding. De novo predicted NTD structure of Delta mutant with both G142D and T95I: residues in red, residue labels in yellow boxes; Delta mutant without G142D or T95I: residues in green and residue labels in light blue boxes. 7L2E: spike residues in orange, residue labels in purple boxes and the solvent excluded surface (SES) in blue. TRP152 residue in the De novo predicted structure of the Delta variant with both G142D and T95I clashes with 7L2E antibody, which is colored in red with and without (inset) the solvent excluded surface (SES) shown in light pink bubble). on D w ue ed nt ut . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.12.21263475 doi: medRxiv preprint Supplemental Figure 2 . Phyre predicted secondary structures of Delta core mutations through one to one threading onto 7L2E, 7C2L, 7YL2 as templates. The prediction is 3-state: either α -helix, β -strand or coil. Green helices represent α -helices, blue arrows indicate β -strands and faint lines indicate coil. The 'SS confidence' line indicates the confidence in the prediction, with red being high confidence and blue low confidence. 

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System

COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance

SARS-CoV-2 evolution and vaccines: cause for concern?

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

High prevalence of SARS-CoV-2 genetic variation and D614G mutation in pediatric patients with COVID-19

The Phyre2 web portal for protein modeling, prediction and analysis

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci Adv

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science

Structure visualization for researchers, educators, and developers

Children's Hospital Los Angeles COVID-19 Analysis Research Database (CARD) -A Resource for Rapid SARS-CoV-2 Genome Identification Using Interactive Online Phylogenetic

Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications. Emerg Microbes Infect

Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations. Emerg Microbes Infect

disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall

Global initiative on sharing all influenza data -from vision to reality

Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading

Evidence for hostdependent RNA editing in the transcriptome of SARS-CoV-2. Sci Adv

Host Immune Response Driving SARS-CoV-2 Evolution. Viruses

Host-directed editing of the SARS-CoV-2 genome

Potential role of host-mediated RNA editing in intra-host variability of SARS-CoV-2 genomes

ADARs: viruses and innate immunity

Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology

The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses

Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants. bioRxiv

High individual heterogeneity of neutralizing activities against the original strain and 9 different variants of SARS-CoV-2